Cidara Therapeutics Free Cash Flow (Quarterly) Trends

Cidara Therapeutics Inc (CDTX)

14.48 +0.58 (+4.17%) USD | NASDAQ | Nov 14, 16:00

14.66 +0.18 (+1.24%) Pre-Market: 20:00

Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2014. Upgrade now.

Date	Value
September 30, 2024	-36.80M
June 30, 2024	-103.78M
March 31, 2024	-6.667M
December 31, 2023	-12.90M
September 30, 2023	-1.76M
June 30, 2023	2.715M
March 31, 2023	-10.99M
December 31, 2022	-21.01M
September 30, 2022	27.96M
June 30, 2022	-11.85M
March 31, 2022	-23.69M
December 31, 2021	-14.91M
September 30, 2021	-11.98M
June 30, 2021	3.423M
March 31, 2021	-1.805M
December 31, 2020	-11.13M
September 30, 2020	-14.14M
June 30, 2020	-14.17M
March 31, 2020	-15.16M
December 31, 2019	-15.20M
September 30, 2019	16.62M
June 30, 2019	-12.83M

Date	Value
March 31, 2019	-17.16M
December 31, 2018	-13.71M
September 30, 2018	-12.87M
June 30, 2018	-15.56M
March 31, 2018	-14.75M
December 31, 2017	-9.631M
September 30, 2017	-13.86M
June 30, 2017	-12.09M
March 31, 2017	-14.63M
December 31, 2016	-11.84M
September 30, 2016	-7.757M
June 30, 2016	-9.635M
March 31, 2016	-10.94M
December 31, 2015	-7.20M
September 30, 2015	-7.854M
June 30, 2015	-5.992M
March 31, 2015	-6.083M
December 31, 2014	-3.318M
September 30, 2014	-3.391M
June 30, 2014	-1.581M
March 31, 2014	-0.411M

Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

-103.78M

Minimum

Jun 2024

27.96M

Maximum

Sep 2022

-14.69M

Average

-12.44M

Median

Free Cash Flow (Quarterly) Benchmarks